Arcellx (ACLX) Non-Current Deffered Revenue (2021 - 2025)

Arcellx's quarterly Non-Current Deffered Revenue came in at $53.1 million in Q4 2025, down 30.13% year-on-year from $76.0 million in Q4 2024, and up 1.28% quarter-over-quarter from $52.4 million in Q3 2025.

Arcellx has reported Non-Current Deffered Revenue for 4 years, with the latest figure at $53.1 million in Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Deffered Revenue fell 30.13% year-over-year to $53.1 million; the trailing twelve-month figure through Dec 2025 stood at $53.1 million (down 30.13% YoY), and the FY2025 full-year result was $53.1 million, down 30.13% from the prior year.
  • Non-Current Deffered Revenue for Q4 2025 stood at $53.1 million, up from $52.4 million in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $170.7 million in Q4 2023, with the low at $1.9 million in Q4 2021.
  • Average Non-Current Deffered Revenue over 4 years is $86.6 million, with a median of $82.6 million recorded in 2024.
  • Peak annual rise in Non-Current Deffered Revenue reached 5.96% in 2024, while the deepest fall reached 55.47% in 2024.
  • Tracing ACLX's Non-Current Deffered Revenue over 4 years: stood at $1.9 million in 2021, then surged by 8906.49% to $170.7 million in 2023, then sank by 55.47% to $76.0 million in 2024, then plunged by 30.13% to $53.1 million in 2025.
  • The last three Non-Current Deffered Revenue figures came in at $53.1 million (Q4 2025), $52.4 million (Q3 2025), and $59.9 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 225.10 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Arcellx 6.48 Bn 6.48 Bn - 53.10 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 53.10 Mn
Sep 30, 2025 52.43 Mn
Jun 30, 2025 59.92 Mn
Mar 31, 2025 69.45 Mn
Dec 31, 2024 76.00 Mn
Sep 30, 2024 82.61 Mn
Jun 30, 2024 96.08 Mn
Mar 31, 2024 112.07 Mn
Dec 31, 2023 170.67 Mn
Sep 30, 2023 121.09 Mn
Jun 30, 2023 124.27 Mn
Mar 31, 2023 105.76 Mn
Dec 31, 2021 1.90 Mn